UFF
GMED icon

USA FINANCIAL FORMULAS’s Globus Medical GMED Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$395 Buy
+5
New +$425 ﹤0.01% 397

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

USA FINANCIAL FORMULAS's GMED Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in Globus Medical (GMED) in Q2 2026: 5 shares worth $395. The stake represents ﹤0.01% of the portfolio and ranks #397 among its holdings.

240 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • USA FINANCIAL FORMULAS held 5 shares of Globus Medical worth $395 as of Q2 2026.
  • Globus Medical was a new USA FINANCIAL FORMULAS position in Q2 2026.
  • Globus Medical made up ﹤0.01% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #397 holding.
  • 240 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.